These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32726210)

  • 1. The Impact of Discharged Loop Diuretic Dose to Home Dose on Hospital Readmissions in Patients with Acute Decompensated Heart Failure: A Retrospective Cohort Study.
    Alshibani M; Alshehri S; Alyazidi W; Alnomani A; Almatruk Z; Almeleebia T
    Heart Surg Forum; 2020 Jul; 23(4):E470-E474. PubMed ID: 32726210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.
    Woodruff AE; Kelley AM; Hempel CA; Loeffler WJ; Echtenkamp CA; Hassan AK
    Ann Pharmacother; 2016 Jun; 50(6):437-45. PubMed ID: 26956954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observation of Patients Transitioned to an Oral Loop Diuretic Before Discharge and Risk of Readmission for Acute Decompensated Heart Failure.
    Laliberte B; Reed BN; Devabhakthuni S; Watson K; Ivaturi V; Liu T; Gottlieb SS
    J Card Fail; 2017 Oct; 23(10):746-752. PubMed ID: 28688888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the first 24 h of loop diuretic on kidney function in acute decompensated heart failure.
    Alshibani M; Alshehri S; Bakhaider A; Atbani A; Ismail M; Jazzar B; Eljaaly K; Althagafi A; Aljabri A
    Ir J Med Sci; 2021 Aug; 190(3):987-992. PubMed ID: 33222077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure.
    Croset F; Llàcer P; Núñez J; Campos J; García M; Pérez A; Fernández C; Fabregate M; López G; Tello S; Fernández JM; Ruiz R; Manzano L
    ESC Heart Fail; 2024 Jun; 11(3):1739-1747. PubMed ID: 38454739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge.
    Matsumoto K; Ehara S; Nakamura Y; Otsuka K; Kawase Y
    Heart Vessels; 2018 Oct; 33(10):1204-1213. PubMed ID: 29687159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
    Rahhal A; Saad MO; Tawengi K; Assi AAR; Habra M; Ahmed D
    BMC Cardiovasc Disord; 2019 May; 19(1):127. PubMed ID: 31138146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dapagliflozin on readmission and loop diuretics use in patients with acute heart failure: a retrospective propensity score-matched cohort study.
    Wu D; Ma Z; Wang X; Wang X; Wang X
    BMC Cardiovasc Disord; 2024 Aug; 24(1):402. PubMed ID: 39090542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
    Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
    ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
    Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
    J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
    Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E
    Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
    DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
    Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Discharge Readiness and Readmission Risk in Patients With Acute Decompensated Heart Failure.
    Oehler A; Kent K; Davis J
    Am J Cardiol; 2018 Dec; 122(12):2086-2094. PubMed ID: 30389090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Mullens W
    Am J Cardiol; 2017 Jul; 120(2):267-273. PubMed ID: 28532770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure.
    Barsuk JH; Gordon RA; Cohen ER; Cotts WG; Malkenson D; Yancy CW; Williams MV
    Congest Heart Fail; 2013; 19(2):53-60. PubMed ID: 23336425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low.
    Verbrugge FH; Martens P; Boonen L; Nijst P; Verhaert D; Noyens P; De Vusser P; Dupont M; Tang WHW; Mullens W
    Acta Cardiol; 2018 Aug; 73(4):335-341. PubMed ID: 28971753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure.
    Testani JM; Brisco MA; Turner JM; Spatz ES; Bellumkonda L; Parikh CR; Tang WH
    Circ Heart Fail; 2014 Mar; 7(2):261-70. PubMed ID: 24379278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study).
    Caughey MC; Sueta CA; Stearns SC; Shah AM; Rosamond WD; Chang PP
    Am J Cardiol; 2018 Jul; 122(1):108-114. PubMed ID: 29703442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VExUS Score at Discharge as a Predictor of Readmission in Patients with Acute Decompensated Heart Failure: A Cohort Study.
    Rinaldi PM; Rihl MF; Boniatti MM
    Arq Bras Cardiol; 2024; 121(5):e20230745. PubMed ID: 38896589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart Failure.
    Yaku H; Kato T; Morimoto T; Inuzuka Y; Tamaki Y; Ozasa N; Yamamoto E; Yoshikawa Y; Kitai T; Taniguchi R; Iguchi M; Kato M; Takahashi M; Jinnai T; Ikeda T; Nagao K; Kawai T; Komasa A; Nishikawa R; Kawase Y; Morinaga T; Toyofuku M; Seko Y; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Shizuta S; Ono K; Sato Y; Kuwahara K; Kimura T;
    JAMA Netw Open; 2019 Jun; 2(6):e195892. PubMed ID: 31225889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.